Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.

Passage Bio, Inc. (($PASG)) announced an update on their ongoing clinical study. Study Overview: Passage Bio, Inc. is conducting a Phase 1b ...

A long-term study found that daily 40Hz light and sound stimulation may help slow cognitive decline in people with late-onset Alzheimer’s disease.

A well-structured plan provides a roadmap for care, helps prevent crises, and ensures that your loved one’s dignity and quality of life remain central to every decision.

In Houston, a 91-year-old sings to his wife of 66 years, while in Louisiana, a 9-year-old raises money for her sister with ...

Listening to or playing music later in life could do more than lift your spirits – it might also help keep your mind sharp. A ...

In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT ...

Individuals diagnosed with cancer appear less likely to later receive a dementia diagnosis, possibly due to biological mechanisms.

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

A fundraising event held in memory of the “joyful presence” brought by a dementia patient who died this year has raised ...